24 November 2022>: Human Study
FLT3 Gene Mutations in Acute Myeloid Leukemia Patients in Northeast Thailand
Nang Ei Ei Aung 1BCD , Supawadee Yamsri 2ACDE* , Nattiya Teawtrakul 3B , Piyawan Kamsaen 4B , Supan Fucharoen 2DGDOI: 10.12659/MSMBR.937446
Med Sci Monit Basic Res 2022; 28:e937446
Table 3 Frequency of FMS-like tyrosine kinase 3 (FLT3)-ITD and tyrosine kinase domain (TKD) mutations in patients with acute myeloid leukemia (AML) from various studies in Asia.
Country | Study design | Age | N | FLT3-ITD (%) | FLT3-TKD | |
---|---|---|---|---|---|---|
(%) | Type of mutations | |||||
This study (Northeast) | Prospective | ≥18 y | 36 | 18.4 | 510.2 | Asp835ValAsp835HisIle836=Ile836Met |
12 | 12.5 | 12.5 | ||||
Kumsaen et al (2016) [] (Northeast)19 | Prospective | ≥18 y | 38 | 21.1 | n/a | n/a |
14 | 14.3 | |||||
Mukda et al (2011) [] (Northeast)19 | Prospective | 64 | 6.3 | 4.8 | n/a | |
Auewarakul et al (2015) [] (Central)17 | Prospective | ≥18 y | 256 | 24.6 | 3.1 | Asp835TyrAsp835HisAsp835GluAsp835AlaI836 deletionAsp835Del +Ile836Val |
Mevatee et al (2015) [] (North)18 | Prospective | ≥18 y | 40 | 25 | n/a | n/a |
Yusoff et al (2019) []20 | Prospective | ≥16 y | 102 | 19 | 3 | n/a |
Mehta et al (2012) []21 | Prospective | ≥15 y | 116 | 19 | 6.9 | n/a |
28 | 17.9 | 3.6 | ||||
Wang et al (2005) []23 | Prospective | ≥15 y | 143 | 25.9 | 6.3 | Asp835Tyr (data from 1 sample) |
Liang et al (2003) []22 | Prospective | 91 | n/a | 3.3 | Asp835TyrAsp835HisAsp835Val | |
Shih et al (2003) []24 | Retrospective (APL only) | >15 y | 94 | 20.2 | 19.1 | Asp835TyrAsp835HisAsp835Val |
≤15 y | 13 | 20 | 15.3 | |||
Yamamoto et al (2001) []25 | Prospective | >15 y | 429 | 20 | 7 | Asp835TyrAsp835HisAsp835ValAsp835Glu |
n/a – not available. |